Currently, the main therapies used for patients with CSCC include surgery followed by adjuvant therapy.2, 3, 4 The present study suggested that TUSC3 may act as a potential tumour suppressor gene in CSCC, which revealed a unique Janus‐like character in cancer pathogenesis and development. Here, TUSC3 is linked to neoplasm.